Firenze Rx presents an effective and streamlined suite of Competitive Intelligence and Strategy solutions designed to enhance RX launch adoption and support lifecycle growth.

The team at Firenze has applied these solutions throughout decades of successful collaborations with major pharmaceutical companies and prominent biopharmaceutical firms.

✔ Competitive benchmarks for Customer Facing organizational frameworks, including Sales, Field Medical, MSL, Nurse Educator, Access, and Patient Hub functions.

✔ In-depth, primary source case studies of both successful and unsuccessful RX drug launches, tailored for client-specific launch analyses and outcomes.

✔ Insights from primary sources and Congress data on current Sales, Market Access, and Patient Access strategies, aligned with competitor functions.

✔ On-demand strategic and tactical evaluations and due diligence supported by primary HUMINT and AI-driven public data sources.

✔ Comprehensive clinical and commercial investigation into emerging competitor pipeline threats.

✔ KOL and Stakeholder identification, along with engagement strategies in the US, EU, and Japan, encompassing hidden advocacy groups and influencing factors.

✔ Mapping the HCP and Patient Journey with key examples from competitors.

✔ Extensive profiling of HEOR, RWE, P/I/I, and PH IV clinical activities to bolster Access and HTA strategies using primary/HUMINT, congress data, and public resources.

Recent areas of focus in specialty and rare diseases include: Oncology, Cardio/Metabolic, Nephrology, Respiratory, Inflammatory, Neurodegenerative, and Psych conditions.